Campbell & Co Investment Adviser’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
+2,892
| New | +$1.17M | 0.07% | 438 |
|
|
2024
Q3 | – | Sell |
-4,781
| Closed | -$2.64M | – | 1332 |
|
|
2024
Q2 | $2.64M | Buy |
+4,781
| New | +$2.64M | 0.22% | 102 |
|
|
2024
Q1 | – | Sell |
-720
| Closed | -$382K | – | 1367 |
|
|
2023
Q4 | $382K | Buy |
+720
| New | +$382K | 0.03% | 830 |
|
|
2023
Q3 | – | Sell |
-657
| Closed | -$343K | – | 1196 |
|
|
2023
Q2 | $343K | Buy |
+657
| New | +$343K | 0.06% | 600 |
|
|
2021
Q4 | – | Sell |
-400
| Closed | -$229K | – | 819 |
|
|
2021
Q3 | $229K | Sell |
400
-300
| -43% | -$172K | 0.07% | 468 |
|
|
2021
Q2 | $353K | Buy |
700
+100
| +17% | +$50.4K | 0.15% | 262 |
|
|
2021
Q1 | $274K | Sell |
600
-900
| -60% | -$411K | 0.17% | 255 |
|
|
2020
Q4 | $699K | Buy |
+1,500
| New | +$699K | 0.43% | 41 |
|
|
2020
Q1 | – | Sell |
-3,650
| Closed | -$1.19M | – | 484 |
|
|
2019
Q4 | $1.19M | Buy |
+3,650
| New | +$1.19M | 0.36% | 36 |
|
|
2018
Q4 | – | Sell |
-2,571
| Closed | -$628K | – | 504 |
|
|
2018
Q3 | $628K | Buy |
2,571
+1,200
| +88% | +$293K | 0.43% | 47 |
|
|
2018
Q2 | $284K | Buy |
+1,371
| New | +$284K | 0.22% | 214 |
|
|
2018
Q1 | – | Sell |
-1,471
| Closed | -$279K | – | 526 |
|
|
2017
Q4 | $279K | Buy |
+1,471
| New | +$279K | 0.21% | 207 |
|
|
2017
Q3 | – | Sell |
-7,459
| Closed | -$1.3M | – | 458 |
|
|
2017
Q2 | $1.3M | Buy |
7,459
+3,961
| +113% | +$691K | 1.21% | 4 |
|
|
2017
Q1 | $537K | Buy |
3,498
+1,110
| +46% | +$170K | 1.39% | 2 |
|
|
2016
Q4 | $337K | Buy |
+2,388
| New | +$337K | 1.04% | 21 |
|
|
2014
Q2 | – | Sell |
-25,240
| Closed | -$3.04M | – | 238 |
|
|
2014
Q1 | $3.04M | Buy |
+25,240
| New | +$3.04M | 1.22% | 25 |
|